.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Dow
Harvard Business School
QuintilesIMS
Colorcon
Medtronic
Chinese Patent Office
Teva
Fish and Richardson

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017535

« Back to Dashboard
NDA 017535 describes LORELCO, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the LORELCO profile page.

The generic ingredient in LORELCO is probucol. There are six drug master file entries for this compound. Additional details are available on the probucol profile page.

Summary for 017535

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 017535

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG
Approval Date:Jul 6, 1988TE:RLD:No

Expired Orange Book Patents for NDA: 017535

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
LORELCO
probucol
TABLET;ORAL017535-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis Us
LORELCO
probucol
TABLET;ORAL017535-002Jul 6, 1988► Subscribe► Subscribe
Sanofi Aventis Us
LORELCO
probucol
TABLET;ORAL017535-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Teva
Cantor Fitzgerald
Farmers Insurance
Federal Trade Commission
Merck
Citi
AstraZeneca
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot